Description
Amnis developed high throughput laboratory automation tools that use a novel molecule detection technology. The Amnis platform has both molecular and cellular-based applications in research and in the clinic. Amnis was acquired by EMD Millipore, the Life Science division of Merck KGaA, in August 2011.
Team Members
David Basiji
Co-founder